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Abstract 
Aims: Coronary artery calcium (CAC) scoring has emerged as a tool for risk 
stratification and potentially for monitoring response to risk factor modification. 
Therefore repeat measurements should provide robust results and low inter-scanner 
variability for allowing meaningful comparison. The purpose of this study was to 
investigate inter-scanner variability of CAC for Agatston-, volume- and mass scores 
by head-to-head comparison using two different cardiac computed tomography 
scanners: 64-detector multislice CT (MSCT) and 64-slice dual-source CT (DSCT).  
Methods and Results: Thirty patients underwent CAC measurements on both 64-
MSCT (GE LightSpeed XT scanner: 120kV, 70mAs, 2.5mm slices) and 64-DSCT 
(Siemens Somatom Definition: 120kV, 80 mAs, 3mm slices) within less than 100 
days (0 - 97). Retrospective intra-scan comparison revealed an excellent correlation. 
The excellent intra-scan (inter-observer) agreement was documented by narrow 
limits of agreement and a correlation coefficient (COV) of r ≥0.99 (p< 0.001) for all 
CAC scores with a low COV for both scanners (64-MSCT/64-DSCT), i.e. Agatston 
(2.0%/2.1%), mass (3.0%/2.0%), and volume (4.7%/3.9%). Inter-scanner comparison 
revealed larger Bland-Altman (BA) limits of agreement, despite high correlation 
(r≥0.97) for all scores, with COV at 15.1%, 21.6% and 44.9% for Agatston, mass and 
volume scores. The largest BA limits were observed for volume scores (-1552.8 to 
574.2), which was massively improved (-241.0 to 300.4, COV 11.5%) after 
reanalyzing the 64-DSCT scans (Siemens) with GE software/workstation (while 
Siemens software/workstation does not allow cross vendor analysis). Phantom 
measurements confirmed overestimation of volume scores by “syngo Ca-Scoring” 
(Siemens) software which should therefore be reviewed (vendor has been notified).  
Conclusion: Intra- and inter-scan agreement of CAC measurement in a given data 
set is excellent. Inter-scanner variability is reasonable, particularly for Agatston units 
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in the clinically most relevant range below 1000. The use of different software 
solutions has a greater influence particularly on volume scores than the use of 
different scanner types. 
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Introduction 
 
The incremental prognostic value of coronary artery calcium (CAC) scoring beyond 
conventional cardiovascular risk factors in different patient populations has been 
reported in a large number of studies.1, 2 As a consequence CAC has become 
increasingly important as a tool to detect atherosclerosis and guide the use of 
measures in prevention of future cardiac events particularly for relatively young and 
asymptomatic patients.3, 4 Due to its noninvasiveness the use of CAC as a tool for 
monitoring response to risk factor modification such as lipid lowering has been 
proposed more than a decade ago.5 The rapid technical advances in multislice 
computed tomography (MDCT) over the last years have led to a switch from the 
electron beam CT (EBCT) on which the CAC was originally introduced by Agatston et 
al.3 to CAC assessment by MDCT. Particularly, the early CT scanner generations 
have been extensively validated against EBCT.1, 6 An increasing number of patients 
is undergoing CAC scoring and potentially repeat scanning for treatment monitoring 7-
10 in different centers with a wide variety of CT scanners from different vendors 
despite the fact that evidence of supporting clinical monitoring by CAC scoring is 
lacking.11 In order to allow meaningful comparison multi-institutional and multi-
manufacturer international standards for quantification of CAC have been published 
by the Physics Task Groups of the International Consortium on Standardization in 
Cardiac CT.12 As a majority of centers performing cardiac CT are now using 64-slice 
CT scanners, the knowledge of inter-scan variability of CAC obtained on this scanner 
generation from different vendors is crucial, but so far lacking. In particular, for 
comparison of data from 64-slice CT versus 64-slice Dual-Source CT (DSCT) only 
phantom data exist.13 Thus, the purpose of the present study was to evaluate the 
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head-to-head inter-scanner variability of CAC values obtained on a 64-slice MDCT 
scanner versus those obtained on a 64-slice DSCT scanner from a different vendor.  
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Methods 
 
Study population 
Thirty consecutive patients who underwent CAC measurements on both different CT 
scanners within an interval of 100 days were included in this study. The unenhanced 
CT scan for CAC scoring was obtained once from the attenuation correction scan at 
the occasion of a myocardial perfusion scintigraphy, which the other CAC scan was 
obtained as routine component of a CT coronary angiography. Thus, both CAC scans 
were obtained from clinically indicated routine examinations. Patients were 
retrospectively included in the study if they had signed informed consent authorizing 
their records to be included in our cardiac imaging research registry. Exclusion 
criteria were: arrhythmia, prior coronary artery bypass surgery or the presence of 
mechanical prosthetic valves, intracoronary artery stents, pacemakers and 
implantable cardioverter defibrillators. Before the study, a detailed interview was 
conducted to collect data on symptoms, previous cardiac events, and cardiovascular 
risk factors as summarized in Table 1. 
 
CT data acquisition 
CAC scanning was performed by non-contrast cardiac CT using a 64-slice MDCT 
scanner (LightSpeed VCT XT, GE Healthcare, Milwaukee, USA) and a 64-slice 
DSCT scanner (Somatom Definition, Siemens Healthcare, Forchheim, Germany). All 
scans were performed in cranio-caudal direction during inspiratory breathold with 
prospective electrocardiogram (ECG)-triggering as previously reported.14 ECG 
triggering was set at 75% of the RR-interval without padding for both scanners. The 
detailed acquisition parameters according to the respective vendors’ 
recommendations for each scanner are given in Table 2. The calcium scores 
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obtained with the two different scanners and respective scanning parameters were 
validated by phantom measurements. A commercially available anthropomorphic 
cardio CT phantom, established and proposed by the Physics Task Group of the 
International Consortium on Standardization in Cardiac CT (in close collaboration 
with the vendors (GE Healthcare, Philips Medical Systems, Siemens Medical 
Solutions and Toshiba Medical Systems)12, consisting of a body (QMR-Thorax, QRM, 
Moehrendorf, Germany) - with artificial lungs and a spine insert surrounded by soft 
tissue equivalent – and a cardiac calcification calibration insert (QRM-CCI, QRM, 
Moehrendorf, Germany) containing nine cylindrical calcifications of different size and 
hydroxyapatite density was examined with both scanners using the same acquisition 
parameters as for the patient study.12, 15-17 
 
CT data evaluation 
All CAC datasets were analysed in random order by two blinded independent 
observers, each with 3 years of experience in cardiac imaging, using commercially 
available software packages of each respective manufacturer (“SmartScore”, GE 
Healthcare, Milwaukee, USA and “Syngo CaScore”, Siemens Healthcare, Forchheim, 
Germany). CAC scores were separately obtained for each of the main epicardial 
coronary arteries (left main artery (LMA), left anterior descending artery (LAD), left 
circumflex artery (LCX), and right coronary artery (RCA)18 and summed to obtain 
total CAC. For every patient, CAC values were calculated using three different 
algorithms according to the recommendations for standardization from the above-
mentioned Consortium12 yielding the Agatston-3, volume-19 and mass scores.20 
Details of these algorithms have been described extensively elsewhere. 12, 21 Briefly, 
their respective formulas are as follows: 
Agatston score = slice increment/slice thickness x Σ (area x cofactor) 
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Mass score = Σ (area x slice increment x mean CT density) x calibration factor 
Volume score = Σ (area x slice increment) 
Σ includes the sum of the values in parenthesis obtained from each individual lesion.  
 
For the phantom study six different cylinders of two sizes (3x3mm and 5x5mm) and 
three different hydroxyapatite (HA) densities (200 mg/cm3 HA, 400 mg/cm3 HA and 
800 mg/cm3 HA) were scored using the same software packages as for the patient 
study.12 
 
Cross vendor analysis 
All images acquired on the 64-DSCT (Siemens) were transferred to the GE 
workstation/software to obtain a cross-vendor analysis of Agatston, mass and volume 
scores. Conversely, Siemens workstation/software does not allow analysing data 
from GE scans. .Therefore we could only perform cross vendor analysis of 64-DSCT 
(Siemens) data on GE software (but not vice versa). 
 
Image quality assessment 
The image quality of CAC scans regarding motion artefacts was visually assessed for 
each coronary artery on a 5-point scale as previously reported22 : 1, no motion 
artefact; 2, minor artefact (slight blurring in less than half of the course of the vessel); 
3, moderate artefact (severe blurring or double-imaged structures in more than half of 
the course of the vessel); 4, severe artefact (doubling and blurring over the whole 
course of the major vessel); 5, non-diagnostic (vessel structures not differentiable).22 
The LMA was assigned to the LAD vessel. 
In addition, image noise was measured by one observer not involved in the image 
quality or reproducibility assessment. It was defined as the standard deviation of 
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attenuation measured in a region of interest (ROI) that was placed in the ascending 
aorta at the level of the coronary ostia. The ROI was chosen as large as possible, 
excluding the vessel wall to avoid partial volume effects. 
 
Radiation dose estimation 
Values for effective radiation dose were calculated by multiplying the dose length 
product (DLP) with a conversion factor (k = 0.014 mSv/mGy x cm) as previously 
described 23 and adopted in large trials.24 
 
Statistical analysis 
Statistical analysis was performed using SPSS software (18.0, SPSS inc., Chicago 
IL, USA). Quantitative variables were expressed as mean ± standard deviation (SD) 
or median (range) as appropriate, and categorical variables as frequencies or 
percentages. Differences in total Calcium scores (for Agatston, mass, and volume 
scores) regarding intra-, inter-observer and inter-scan comparison were analysed by 
Wilcoxon signed ranks test. To assess intra-observer variability, each reader 
evaluated all datasets twice after a minimum delay of two weeks. Inter-scan 
agreement was performed by comparing CAC obtained on the two scanner types in 
each patient. Intra- and inter-observer variability as well as inter-scan agreement 
were assessed using Spearman’s correlation and Bland-Altman (BA) analysis with 
limits of agreement as previously reported.25 Data were log (log10) transformed to 
reduce skewness of the given values and used to show regression analyses. The 
coefficient of variation (COV) was calculated as SD/mean and expressed as a 
percentage for better comparison of the values. The standard error of the estimates 
was assessed to characterize the linear fit of the data.  
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Image quality was correlated to the mean heart rate and differences in image quality 
between 64-MDSCT and 64-DSCT were assessed using Chi-square test. Differences 
in image noise were tested with Wilcoxon signed rank test and the influence of body 
mass index (BMI) on image noise was evaluated by regression analysis. All P values 
were two-sided and a P value <0.05 was considered statistically significant.  
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Results 
 
Study population 
Thirty patients (7 female, age 71±8 years, BMI: 254 kg/m2) underwent successful 
scanning on both scanner types (64-MDCT and 64-DSCT) within 23 ± 27 days (range 
0 - 97 days) and were included in the present study The patient baseline 
characteristics are listed in Table 1. The sequence of CAC scanning was: 64-MDCT 
first in 19 patients, and 64-DSCT first in 11 patients. None of the patients received 
intravenous beta-receptor antagonists prior to the scan. 
 
Phantom study 
Calcium scores of the six inserts obtained with the two scanners in the phantom were 
nearly identical regarding Agatston score (64-DSCT: 695; 64-MDCT: 690) and highly 
accurate for the mass scores (calibrated phantom mass: 167 mg; 64-DSCT: 167 mg; 
64-MDCT: 165 mg) (Table 3). However, while volume scores from 64-MDCT were 
slightly underestimated for low density lesions, volume scores from 64-DSCT were 
highly overestimated for intermediate and high density lesions. Thus, the differences 
in volume scores could be largely attributed to the software used for CAC scoring 
rather than the scanner.  
In fact, when the volume scores from 64-DSCT Siemens scanner and Siemens 
software were recalculated by the GE software the values were substantially closer to 
the phantom values (Table 3), indicating that not the Siemens scanner but rather the 
quantification algorithm in the Siemens software “syngo CaScoring” accounted for the 
inaccurate volume score measurements in intermediate and high density lesions 
(Figure 4). 
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Intra-scan comparison: Intra- and Inter-observer variation 
Intra- and inter-observer agreements of Agatston, mass, and volume scores were 
excellent for both scanner types as evidenced by strong and significant correlations 
with narrow limits of agreement (Table 4).  
 
Inter-scanner comparison 
For all inter-scanner CAC measurements results are summarized in Table 5 and 
illustrated in Figure 1. Inter-scanner comparison for Agatston scores revealed an 
excellent correlation (r = 0.976, P <0.01), despite relatively wide limits of agreement 
and a COV of 15.1%. Mass score comparison between the two scanners also 
revealed excellent correlation (r = 0.975, P <0.01) with a COV of 21.6%. Although, 
inter-scan correlation of volume scores was also excellent (r = 0.971, P <0.01), BA 
analysis revealed wide limits of agreement and a substantial bias towards lower 
values from 64-MDCT compared to 64-DSCT resulting in high COV 44.9%. 
 
Cross vendor analysis 
Interestingly, by use of GE software for Siemens scans the COV decreased 
substantially compared to original analysis for the Agatston (10.4% vs. 15.1%), mass 
(16.5% vs. 21.6%) and particularly for volume (11.5% vs. 44.9%) scores. (Table 5 
and Figure 2 and 3). 
 
CAC image quality 
There was no significant difference in image quality between the two scanners 
(Figure 4) for any of the coronary vessels and for the overall image quality (Table 6). 
However, overall image quality tended to be superior in 64-DSCT. Diagnostic image 
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quality was found in all 64-DSCT and 64-MDCT scans. For both scanners image 
quality was significantly inferior in the RCA vs. LCX. (P <0.05). 
Image noise tended to be lower in 64-MDCT compared to 64-DSCT (21.0 HU ± 6.6 
HU) vs. (23.4 HU ± 6.6 HU) without reaching statistical significance (P >0.067). 
Regression analysis showed a statistically significant influence of the patient’s BMI 
on image noise for both scanner types (P <0.05). 
 
Radiation dose 
The average DLP was 73 ± 28.6 mGy x cm (effective dose: 1 ± 0.4mSv) on 64-
MDCT, and 65.7 ± 33.1 mGy x cm (effective dose: 0.9 ± 0.5mSv) on 64-DSCT 
respectively (n.s.).  
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Discussion 
 
The present study reports an excellent intra- and inter-observer reproducibility and a 
good inter-scanner agreement of coronary CAC assessment between a 64-slice 
MDCT and a 64-slice DSCT scanner from two different vendors, with decreasing 
agreement at increasing calcium scores. 
The Multi-Ethnic Study of Atherosclerosis (MESA) has also evaluated inter-scan 
variability and provided repeatability limits.6, 26 These limits are important in order to 
evaluate whether an increase in CAC score exceeds that expected from natural 
progression or that of measurement error alone.27 The present study confirms an 
excellent intra- and inter-observer reproducibility of CAC on each scanner. For all 
scores including Agatston-, volume- and mass scores across a wide range of CAC 
values. The present data on intra- and inter-observer reproducibility are in line with 
previous findings. 28 
Our study is the first to report a head-to-head inter-scanner comparison between two 
of the most widely used scanner types. Only few studies have reported similar 
comparisons29, 30 and theses comparisons were made by using techniques which are 
now outdated. For Agatston scores we found a COV of 15.1% comparing well to the 
values reported in the literature (19-37%). 
 19, 20, 31-33. Inter-scanner variability for mass score was 21.6% while it was 
substantially higher for the volume scores (44.9%) despite similar intra- or inter-
observer variability for this measurement. Interestingly, when recalculating CAC from 
64-DSCT scans (Siemens) using the workstation/software of the other vendor (GE), 
there was a significant decrease in volume scores, resulting in a substantial reduction 
of the COV to 11.5%. Although our results suggest that accurate and reliable CAC 
data can be obtained from both scanners values of volume scores differ significantly 
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from the two vendors, mainly due to differences in the quantification algorithm 
although differences in slice thickness may lead to differenced in partial volume 
artefact affecting predominantly the volume score.  
The phantom measurements revealed a slight underestimation (-30%) of volume 
scores in low density lesions by GE software/workstation. By contrast, a massive 
overestimation of volume scores has been found in intermediate (+100%) and high 
density lesions (+159%) by Siemens software/workstation (Figure 3) which should 
therefore be reviewed (vendor has been notified).  
From the BA plot for Agatston scores it can be concluded that despite a good 
correlation over the whole range of values the agreement is best for values below 
1000, while it decreases in patients with extensive calcifications. This is important 
because absolute precision of repeat measurements appears most relevant in 
patients without excessive calcifications, in whom risk factor modification may slow 
progression and therefore its monitoring may be appropriate. The volume score has 
been suggested as a favourable alternative to the traditional Agatston score as it 
allows robust assessment of the extent to which the volume of atherosclerosis plaque 
may decrease, stabilize or increase using lipid lowering treatment. 5, 20 
The multimanufacturer international standards for CAC measuring12 may have, at 
least in part, contributed to the robustness of such measurements even in cross-
vendor comparison. This now allows tracking atherosclerosis progression on different 
scanners from different vendors19, 20 although accuracy of the results calculated from 
various types of software on different workstations may require validation against a 
reference phantom. Whether the variance of measurements as evidenced in the 
present study allows obtaining clinically acceptable results will remain a matter of 
clinical judgement in each study setting. Across the literature progression of CAC 
score is generally given as percent change from the baseline value because greater 
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absolute changes are observed in patients with higher baseline scores in whom even 
large CAC increase does not necessarily reflect a pronounced clinical deterioration.21 
34-38 Raggi et al. have suggested a change >15% for Agatston score within one year 
as a clinically meaningful progression.34 In fact, relatively large increases in CAC in 
patients with extensive calcifications do not necessarily reflect a pronounced clinical 
deterioration.20 
The inter-scanner COV for Agatston scores (15.1%) lies substantially below the 
typically reported values of the annual CAC progression rates of 20% to 24% per 
year.21 Thus, while intervals shorter than 1-2 years may be of questionable value,11, 39 
monitoring CAC progression over time does not necessarily require the repeat scan 
being performed on the same device of the same vendor. At present, an 
individualized algorithm, rather than a systematic performance of serial CAC 
measurement seems appropriate based on the existing evidence.39 
 
Study Limitations 
First, we do not have data on repeat measurements on the same scanner which 
would directly support the notion that rescanning should be performed on the same 
scanner for obtaining optimal agreement, although published data seem to suggest 
this.40 However, such analysis was beyond the scope of the present study because it 
would require 4 scans per patient, i.e. two scans in each subject with each scanner. 
Second, in the present study, no systematic use of beta blocker for heart rate 
regulation and slowing was implemented. Although this may account for some part of 
the inter-scan variability, the fact that each patient served as his own control may 
have counterbalanced this drawback strengthening the validity of our data. In this 
context it should be emphasized, that the design of the present study does not allow 
evaluating systematic technology related biases towards higher accuracy of one type 
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of scanner over the other. This is particularly true for Agatston score which 
represents a mathematical construct and therefore cannot be compared to a physical 
standard of reference in contrast to mass and volume scores. 
Finally, the median Agatston score was over 750 indicating that the patients 
represent a high risk population which potentially limits the generalizability of our 
results. On the other hand, however, inclusion of many patients without coronary 
calcifications would have added only limited information to CAC comparability. We 
therefore, felt it preferable including a wide range of CAC (0-5156 Agatston score).  
 
Conclusion 
Intra-scanner variability (intra- and inter-observer comparison of CAC scoring in a 
given data set is excellent. Inter-scanner variability is reasonable, particularly for 
Agatston scoring in the clinically most relevant range below 1000. The use of 
different software solutions for CAC scoring has a greater influence on volume scores 
than the use of different scanner types. 
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Figure Legends 
 
Figure 1 Inter-scanner correlations (left panel, logarithmic scale) and Bland-Altman 
limits of agreement (right panel) are given for Agatston (A), mass (B), and volume 
score (C). Scans were analyzed by dedicated software and workstation from scanner 
vendor as for scanner on which data was acquired. AU indicates Agatston Units. 
 
Figure 2 The reanalysis of Siemens scans by GE software/workstation eliminates the 
variability introduced by differences in dedicated software/workstation. This is 
illustrated by narrowing of Bland Altman limits of agreement compared to Figure 1 for 
Agatston (A), mass (B), and most impressively for volume score (C). As GE data and 
Siemens software are not compatible no such cross-vendor analysis is available.  
 
Figure 3 In intermediate (400mg/cm3) and high density (800mg/cm3) lesions 64-
DSCT (Siemens) substantially overestimates the volume scores, while 64-MDCT 
(GE) slightly underestimates volume scores in low density lesions (200mg/cm3) 
compared to calibrated phantom which has been previously established.12 
 
Figure 4 Axial images demonstrating calcifications in all three epicardial vessels of a 
70-year old patient with equal image quality from nonenhanced 64-MDCT (GE) (A) 
and form 64-DSCT (Siemens) (B). 
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